VELLUM BIOTECHNOLOGY, INC.

Medtech · Private

Automated nucleic acid purification system optimized for extracting DNA and RNA from formalin-fixed paraffin-embedded tissue samples

Grants
$2.0M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Developing a New Nucleic Acid Extraction Technology to Enable High Quality DNA Sequencing for Formalin Fixed Paraffin Embedded Tissue Samples$1,020,280
Federal grantDepartment of Health and Human Services · Phase II · Developing a New Nucleic Acid Extraction Technology to Enable High Quality DNA Sequencing for Formalin Fixed Paraffin Embedded Tissue Samples$1,014,715
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2114MOREMME-JAVORE LLC——
2115INPRINT BIO LLC——
2116LUCIE MEDICAL INC——
2117VELLUM BIOTECHNOLOGY, INC.——
2118HYDRONOVO, INC——
2119ANTIXERO——
2120LUMINA MEDICAL LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.